The Effects of the Telomerase Activator TA-65 on Insulin Resistance, Inflammation, and Metabolic Syndrome

NCT01753674 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

13

Enrollment

OTHER

Sponsor class

Stopped non-compliance issues

Conditions

Metabolic Syndrome
Insulin Resistance

Interventions

DIETARY_SUPPLEMENT: TA-65
DIETARY_SUPPLEMENT: Placebo

Sponsor

University of Connecticut